Notably, TRM cells in ovarian cancer show features of activated T cells, such as an elevated surface expression of HLA-DR coupled to the downregulation of CD127 (IL-7Rα), and the co-expression of the proliferation marker Ki67 [113]. This evidence concerns the gene IL7R and ovarian cancer.